TP53 and cancer: In this manuscript, we expand on the correction of cancer driver mutations in a single cell line [37], and explore the correction of five cancer hotspot mutations across six distinct cell lines and integrate adenine base editing with transcriptomic profiling to assess the functional impact of correcting two different TP53 mutations.